OBJECTIVE: To determine the effectiveness of structured adherence counseling by pharmacists on the eradication of Helicobacter pylori when using a standard drug treatment regimen. DESIGN: Randomized controlled clinical trial. SETTING:Nonprofit group-practice health maintenance organization (HMO). PARTICIPANTS: HMO primary care providers referred 1,393 adult dyspeptic patients for carbon 14 urea breath testing (UBT). INTERVENTIONS: Those whose tests were positive for H pylori (23.3%) were provided a standard antibiotic regimen and randomly assigned to receive either usual-care counseling from a pharmacist or a longer adherence counseling session and a follow-up phone call from the pharmacist during drug treatment. All subjects were given the same 7-day course of omeprazole, bismuth subsalicylate, metronidazole, and tetracycline hydrochloride (OBMT). Dyspepsia symptoms were recorded at baseline and following therapy. OUTCOMES: The main outcome was eradication of H pylori as measured by UBT at 3-month follow-up. Secondary outcomes were patient satisfaction and dyspepsia symptoms at 3-month follow-up. RESULTS: Of the 333 participants randomly assigned to treatment, 90.7% completed the 3-month follow-up UBT and questionnaires. Overall eradication rate with the OBMT regimen was 80.5% with no significant difference in eradication rates between the 2 groups (P=0.98). Conclusions In this study, additional counseling by pharmacists did not affect self-reported adherence to the treatment regimen, eradication rates, or dyspepsia symptoms but did increase patient satisfaction.
RCT Entities:
OBJECTIVE: To determine the effectiveness of structured adherence counseling by pharmacists on the eradication of Helicobacter pylori when using a standard drug treatment regimen. DESIGN: Randomized controlled clinical trial. SETTING: Nonprofit group-practice health maintenance organization (HMO). PARTICIPANTS: HMO primary care providers referred 1,393 adult dyspepticpatients for carbon 14 urea breath testing (UBT). INTERVENTIONS: Those whose tests were positive for H pylori (23.3%) were provided a standard antibiotic regimen and randomly assigned to receive either usual-care counseling from a pharmacist or a longer adherence counseling session and a follow-up phone call from the pharmacist during drug treatment. All subjects were given the same 7-day course of omeprazole, bismuth subsalicylate, metronidazole, and tetracycline hydrochloride (OBMT). Dyspepsia symptoms were recorded at baseline and following therapy. OUTCOMES: The main outcome was eradication of H pylori as measured by UBT at 3-month follow-up. Secondary outcomes were patient satisfaction and dyspepsia symptoms at 3-month follow-up. RESULTS: Of the 333 participants randomly assigned to treatment, 90.7% completed the 3-month follow-up UBT and questionnaires. Overall eradication rate with the OBMT regimen was 80.5% with no significant difference in eradication rates between the 2 groups (P=0.98). Conclusions In this study, additional counseling by pharmacists did not affect self-reported adherence to the treatment regimen, eradication rates, or dyspepsia symptoms but did increase patient satisfaction.
Authors: B J Marshall; M W Plankey; S R Hoffman; C L Boyd; K R Dye; H F Frierson; R L Guerrant; R W McCallum Journal: Am J Gastroenterol Date: 1991-04 Impact factor: 10.864
Authors: C P Dooley; H Cohen; P L Fitzgibbons; M Bauer; M D Appleman; G I Perez-Perez; M J Blaser Journal: N Engl J Med Date: 1989-12-07 Impact factor: 91.245
Authors: E Hentschel; G Brandstätter; B Dragosics; A M Hirschl; H Nemec; K Schütze; M Taufer; H Wurzer Journal: N Engl J Med Date: 1993-02-04 Impact factor: 91.245
Authors: J Parsonnet; S Hansen; L Rodriguez; A B Gelb; R A Warnke; E Jellum; N Orentreich; J H Vogelman; G D Friedman Journal: N Engl J Med Date: 1994-05-05 Impact factor: 91.245
Authors: Robby Nieuwlaat; Nancy Wilczynski; Tamara Navarro; Nicholas Hobson; Rebecca Jeffery; Arun Keepanasseril; Thomas Agoritsas; Niraj Mistry; Alfonso Iorio; Susan Jack; Bhairavi Sivaramalingam; Emma Iserman; Reem A Mustafa; Dawn Jedraszewski; Chris Cotoi; R Brian Haynes Journal: Cochrane Database Syst Rev Date: 2014-11-20
Authors: Christine Y Lu; Dennis Ross-Degnan; Stephen B Soumerai; Sallie-Anne Pearson Journal: BMC Health Serv Res Date: 2008-04-07 Impact factor: 2.655
Authors: Maarten Lambert; Chloé C H Smit; Stijn De Vos; Ria Benko; Carl Llor; W John Paget; Kathryn Briant; Lisa Pont; Liset Van Dijk; Katja Taxis Journal: Br J Clin Pharmacol Date: 2022-02-28 Impact factor: 3.716